Jasper Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2024 | 11.22 M | $8.55 M | 0.00% | 10.23% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2024 | 9.87 M | $7.79 M | 18.91% | 9.00% |
| CARLYLE GROUP INC. | 02/02/2024 | 8.76 M | $6.67 M | 0.00% | 7.99% |
| QIMING U.S. VENTURES MANAGEMENT, LLC | 02/14/2024 | 8.52 M | $6.72 M | 0.00% | 7.76% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2024 | 4.47 M | $3.53 M | 0.00% | 4.07% |
| VANGUARD GROUP INC | 03/11/2024 | 4.09 M | $3.23 M | 7.91% | 3.73% |
| OPALEYE MANAGEMENT INC. | 02/14/2024 | 3.99 M | $3.14 M | 100.00% | 3.63% |
| ALLY BRIDGE GROUP (NY) LLC | 02/14/2024 | 3.66 M | $28.87 M | 16.38% | 3.34% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 03/18/2024 | 3.54 M | $2.79 M | 16.45% | 3.23% |
| BANK OF AMERICA CORP /DE/ | 02/14/2024 | 3.18 M | $2.51 M | -0.01% | 2.90% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/15/2024 | 2.23 M | $1.76 M | -7.27% | 2.03% |
| WOODLINE PARTNERS LP | 02/14/2024 | 1.73 M | $1.37 M | -42.23% | 1.58% |
| MORGAN STANLEY | 08/16/2024 | 1.70 M | $1.34 M | 117.65% | 1.55% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2024 | 1.39 M | $1.09 M | -0.06% | 1.26% |
| BLACKROCK INC. | 02/13/2024 | 1.32 M | $1.04 M | 0.24% | 1.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 904,477 | $713,779 | 0.00% | 0.82% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/05/2024 | 789,331 | $622,782 | 100.00% | 0.72% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/15/2024 | 713,063 | $5.63 M | -87.46% | 0.65% |
| MARINER, LLC | 02/14/2024 | 590,510 | $465,912 | -9.53% | 0.54% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 514,324 | $406,000 | 65.80% | 0.47% |
| BANK OF MONTREAL /CAN/ | 02/08/2024 | 348,300 | $278,640 | 100.00% | 0.32% |
| MONACO ASSET MANAGEMENT SAM | 02/07/2024 | 249,563 | $196,905 | 100.00% | 0.23% |
| STATE STREET CORP | 02/14/2024 | 229,994 | $181,465 | 0.00% | 0.21% |
| COWEN AND COMPANY, LLC | 02/12/2024 | 200,000 | $157,800 | -0.20% | 0.18% |
| CITADEL ADVISORS LLC | 02/14/2024 | 191,155 | $150,821 | 144.05% | 0.17% |
| NORTHERN TRUST CORP | 02/13/2024 | 154,909 | $122,223 | 0.00% | 0.14% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 129,883 | $102,478 | 108.45% | 0.12% |
| SUMMIT TRAIL ADVISORS, LLC | 02/06/2024 | 65,000 | $51,285 | 0.00% | 0.06% |
| IEQ CAPITAL, LLC | 02/07/2024 | 54,500 | $43,001 | 100.00% | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2024 | 54,168 | $42,739 | -18.04% | 0.05% |
| BANK OF NEW YORK MELLON CORP | 01/29/2024 | 43,593 | $34,395 | 0.00% | 0.04% |
| CITADEL ADVISORS LLC | 02/14/2024 | 39,200 | $30,929 | -43.11% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2024 | 36,899 | $29,113 | 0.00% | 0.03% |
| GRIES FINANCIAL LLC | 02/13/2024 | 23,845 | $18,814 | 0.00% | 0.02% |
| LAZARD ASSET MANAGEMENT LLC | 02/14/2024 | 11,500 | $8,000 | 3.23% | 0.01% |
| JANE STREET GROUP, LLC | 02/15/2024 | 11,209 | $8,844 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 11,144 | $8,793 | 100.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 609 | $481 | -18.69% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/14/2024 | 1 | $1 | 0.00% | 0.00% |
| FRANKLIN RESOURCES INC | 02/09/2024 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 02/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BVF INC/IL | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SCOGGIN MANAGEMENT LP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 02/05/2024 | 0 | $0 | -100.00% | 0.00% |
| FOREFRONT ANALYTICS, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| IKARIAN CAPITAL, LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
Jasper Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Jasper Therapeutics, Inc.. The most heavily invested institutionals were:
One68 Global Capital, LLC: 20,000
Abingworth LLP: 5.63 M
Grace Capital: 218,110
68.35% of Jasper Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.87 M shares in the last 24 months. This purchase volume represents approximately $41.18 M in transactions.